Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126919911 | 12691991 | 1 | I | 201604 | 20160526 | 20160827 | 20160827 | PER | US-ASTRAZENECA-2016SE57685 | ASTRAZENECA | 989.00 | MON | F | Y | 81.60000 | KG | 20160827 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126919911 | 12691991 | 1 | PS | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | Respiratory (inhalation) | 160/4.5MCG 2 PUFFS TWICE DAILY | 21929 | ||||||||||
| 126919911 | 12691991 | 2 | SS | ESOMEPRAZOLE | ESOMEPRAZOLE | 1 | Oral | U | U | 0 | 20 | MG | QD | ||||||
| 126919911 | 12691991 | 3 | C | SPIRIVA | TIOTROPIUM BROMIDE MONOHYDRATE | 1 | Respiratory (inhalation) | DAILY | 0 | ||||||||||
| 126919911 | 12691991 | 4 | C | PROAIR HFA RESCUE INHALER | 2 | Respiratory (inhalation) | AS REQUIRED | 0 | |||||||||||
| 126919911 | 12691991 | 5 | C | LOSARTAN. | LOSARTAN | 1 | Oral | 0 | 12.5 | MG | QD | ||||||||
| 126919911 | 12691991 | 6 | C | FAMATODINE | FAMOTIDINE | 1 | Oral | 0 | 60 | MG | QD | ||||||||
| 126919911 | 12691991 | 7 | C | SOTALAPRAM | 2 | Oral | 0 | 40 | MG | QD | |||||||||
| 126919911 | 12691991 | 8 | C | CLONAZAPAM | CLONAZEPAM | 1 | Oral | 0 | .5 | MG | QD | ||||||||
| 126919911 | 12691991 | 9 | C | CALTRATE WITH VITAMIN D | CALCIUM CARBONATECHOLECALCIFEROL | 1 | 0 | QD | |||||||||||
| 126919911 | 12691991 | 10 | C | MOVE FREE JOINT HEALTH | 2 | Oral | 0 | QD | |||||||||||
| 126919911 | 12691991 | 11 | C | OSTEOBIFLEX | 2 | Oral | DAILY | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126919911 | 12691991 | 1 | Asthma |
| 126919911 | 12691991 | 2 | Gastrooesophageal reflux disease |
| 126919911 | 12691991 | 3 | Asthma |
| 126919911 | 12691991 | 4 | Cough |
| 126919911 | 12691991 | 5 | Blood pressure measurement |
| 126919911 | 12691991 | 6 | Bone disorder |
| 126919911 | 12691991 | 7 | Gastrooesophageal reflux disease |
| 126919911 | 12691991 | 8 | Panic attack |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126919911 | 12691991 | Arthritis | |
| 126919911 | 12691991 | Asthma | |
| 126919911 | 12691991 | Drug ineffective | |
| 126919911 | 12691991 | Obstructive airways disorder | |
| 126919911 | 12691991 | Wrong technique in product usage process |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126919911 | 12691991 | 1 | 2006 | 0 | ||
| 126919911 | 12691991 | 2 | 2006 | 0 | ||
| 126919911 | 12691991 | 3 | 201605 | 0 | ||
| 126919911 | 12691991 | 4 | 2006 | 0 | ||
| 126919911 | 12691991 | 5 | 2006 | 0 | ||
| 126919911 | 12691991 | 6 | 2006 | 0 | ||
| 126919911 | 12691991 | 7 | 2006 | 0 | ||
| 126919911 | 12691991 | 8 | 2006 | 0 | ||
| 126919911 | 12691991 | 9 | 2006 | 0 | ||
| 126919911 | 12691991 | 10 | 201603 | 0 | ||
| 126919911 | 12691991 | 11 | 201603 | 0 |